These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25787747)

  • 41. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal.
    Rasmussen K; Vandergriff J
    Neuropharmacology; 2003 Jan; 44(1):88-92. PubMed ID: 12559125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses.
    Xu NJ; Bao L; Fan HP; Bao GB; Pu L; Lu YJ; Wu CF; Zhang X; Pei G
    J Neurosci; 2003 Jun; 23(11):4775-84. PubMed ID: 12805317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis.
    Rasmussen K; Aghajanian GK
    Brain Res; 1989 Dec; 505(2):346-50. PubMed ID: 2598056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
    Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
    Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal.
    Javelle N; Bérod A; Renaud B; Lambás-Señas L
    Neuroreport; 2002 Apr; 13(5):725-8. PubMed ID: 11973478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal.
    Zachariou V; Thome J; Parikh K; Picciotto MR
    Neuropsychopharmacology; 2000 Aug; 23(2):127-37. PubMed ID: 10882839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals.
    Guitart X; Kogan JH; Berhow M; Terwilliger RZ; Aghajanian GK; Nestler EJ
    Brain Res; 1993 May; 611(1):7-17. PubMed ID: 8518951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats.
    Krystal JH; Compere S; Nestler EJ; Rasmussen K
    Physiol Behav; 1996; 59(4-5):863-6. PubMed ID: 8778878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
    Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat.
    Feng YZ; Zhang T; Rockhold RW; Ho IK
    Neurochem Res; 1995 Jun; 20(6):745-51. PubMed ID: 7566372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
    Hoshi K; Ma T; Ho IK
    Eur J Pharmacol; 1996 Oct; 314(3):301-6. PubMed ID: 8957250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression.
    Mannelli P; Gottheil E; Peoples JF; Oropeza VC; Van Bockstaele EJ
    Biol Psychiatry; 2004 Aug; 56(4):261-8. PubMed ID: 15312814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanisms.
    Rossetti ZL; Longu G; Mercuro G; Gessa GL
    Brain Res; 1993 Apr; 609(1-2):316-20. PubMed ID: 8508313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pannexin-1 channel inhibition alleviates opioid withdrawal in rodents by modulating locus coeruleus to spinal cord circuitry.
    Kwok CHT; Harding EK; Burma NE; Markovic T; Massaly N; van den Hoogen NJ; Stokes-Heck S; Gambeta E; Komarek K; Yoon HJ; Navis KE; McAllister BB; Canet-Pons J; Fan C; Dalgarno R; Gorobets E; Papatzimas JW; Zhang Z; Kohro Y; Anderson CL; Thompson RJ; Derksen DJ; Morón JA; Zamponi GW; Trang T
    Nat Commun; 2024 Jul; 15(1):6264. PubMed ID: 39048565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Afferent effects on locus coeruleus in opiate withdrawal.
    Rasmussen K
    Prog Brain Res; 1991; 88():207-16. PubMed ID: 1839935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray.
    Punch LJ; Self DW; Nestler EJ; Taylor JR
    J Neurosci; 1997 Nov; 17(21):8520-7. PubMed ID: 9334424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input.
    Akaoka H; Aston-Jones G
    J Neurosci; 1991 Dec; 11(12):3830-9. PubMed ID: 1683899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of orexin type-1 receptors in locus coeruleus nucleus attenuates the development of morphine dependency in rats.
    Mousavi Y; Azizi H; Mirnajafi-Zadeh J; Javan M; Semnanian S
    Neurosci Lett; 2014 Aug; 578():90-4. PubMed ID: 24970749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats.
    Ghaemi-Jandabi M; Azizi H; Ahmadi-Soleimani SM; Semnanian S
    Brain Res Bull; 2017 Apr; 130():107-111. PubMed ID: 28093335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.